Although SGLT2-Is is mainlyused as a hypoglycemic agent, Hwang et al. [26] has shown that SGLT2-Iscan improve left ventricular systolic and diastolic function and left ventriculargeometry in diabetic patients regardless of whether heart failure is present. This evidence concerns the gene SLC5A2 and heart failure.